Research progress of functional imaging-assisted radiotherapy target delineation of lung cancer with atelectasis

doi:10.3760/cma.j.cn371439-20210408-00007

Abstract

Abstract:

Radiotherapy is one of the main treatment methods for patients with lung cancer, especially for patients with locally advanced lung cancer. Local advanced lung cancer is often accompanied by atelectasis, so it brings great difficulty and uncertainty to the delineation of radiotherapy target, and then affects the curative effect of patients. The latest research shows that functional imaging has a unique imaging principle, which can truly reflect biological information such as tumor proliferation and metabolism, and has an application prospect in distinguishing the target area of lung cancer from atelectasis.

Key words: Lung neoplasms, Pulmonary atelectasis, Radiotherapy

Zhang Hongjiao, Jiang Jie, Huang Wei. Research progress of functional imaging-assisted radiotherapy target delineation of lung cancer with atelectasis[J]. Journal of International Oncology, 2022, 49(1): 51-55.

References 44

[1]	Karki K, Saraiya S, Hugo GD, et al. Variabilities of magnetic resonance imaging-, computed tomography-, and positron emission tomography-computed tomography-based tumor and lymph node delineations for lung cancer radiation therapy planning[J]. Int J Radiat Oncol Biol Phys, 2017, 99(1):80-89. DOI: 10.1016/j.ijrobp.2017.05.002. doi: 10.1016/j.ijrobp.2017.05.002
[2]	Prathipati A, Manthri RG, Subramanian BV, et al. A prospective study comparing functional imaging (¹⁸F-FDG PET) versus anatomical imaging (contrast enhanced CT) in dosimetric planning for non-small cell lung cancer[J]. Asia Ocean J Nucl Med Biol, 2017, 5(2):75-84. DOI: 10.22038/aojnmb.2017.8706. doi: 10.22038/aojnmb.2017.8706 pmid: 28660217
[3]	Sibille L, Seifert R, Avramovic N, et al. ¹⁸F-FDG PET/CT uptake classification in lymphoma and lung cancer by using deep convolutional neural networks[J]. Radiology, 2020, 294(2):445-452. DOI: 10.1148/radiol.2019191114. doi: 10.1148/radiol.2019191114
[4]	Konert T, Vogel WV, Paez D, et al. Introducing FDG PET/CT-guided chemoradiotherapy for stage Ⅲ NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial[J]. Eur J Nucl Med Mol Imaging, 2019, 46(11):2235-2243. DOI: 10.1007/s00259-019-04421-5. doi: 10.1007/s00259-019-04421-5
[5]	Schaefer A, Kim YJ, Kremp S, et al. PET-based delineation of tumour volumes in lung cancer: comparison with pathological findings[J]. Eur J Nucl Med Mol Imaging, 2013, 40(8):1233-44. DOI: 10.1007/s00259-013-2407-x. doi: 10.1007/s00259-013-2407-x
[6]	Kajáry K, Lengyel Z, Tokés AM, et al. Dynamic FDG-PET/CT in the initial staging of primary breast cancer: clinicopathological correlations[J]. Pathol Oncol Res, 2020, 26(2):997-1006. DOI: 10.1007/s12253-019-00641-0. doi: 10.1007/s12253-019-00641-0
[7]	Bianconi F, Palumbo I, Fravolini ML, et al. Texture analysis on [¹⁸F]FDG PET/CT in non-small-cell lung cancer: correlations between PET features, CT features, and histological types[J]. Mol Imaging Biol, 2019, 21(6):1200-1209. DOI: 10.1007/s11307-019-01336-3. doi: 10.1007/s11307-019-01336-3
[8]	Yin LJ, Yu XB, Ren YG, et al. Utilization of PET-CT in target volume delineation for three-dimensional conformal radiotherapy in patients with non-small cell lung cancer and atelectasis[J]. Multidiscip Respir Med, 2013, 8(1):21. DOI: 10.1186/2049-6958-8-21. doi: 10.1186/2049-6958-8-21
[9]	Fonti R, Conson M, Del Vecchio S. PET/CT in radiation oncology[J]. Semin Oncol, 2019, 46(3):202-209. DOI: 10.1053/j.seminoncol.2019.07.001. doi: S0093-7754(19)30079-X pmid: 31378377
[10]	Flechsig P, Rastgoo R, Kratochwil C, et al. Impact of computer-aided CT and PET analysis on non-invasive T staging in patients with lung cancer and atelectasis[J]. Mol Imaging Biol, 2018, 20(6):1044-1052. DOI: 10.1007/s11307-018-1196-9. doi: 10.1007/s11307-018-1196-9 pmid: 29679299
[11]	Fiset S, Welch ML, Weiss J, et al. Repeatability and reproducibility of MRI-based radiomic features in cervical cancer[J]. Radiother Oncol, 2019, 135:107-114. DOI: 10.1016/j.radonc.2019.03.001. doi: 10.1016/j.radonc.2019.03.001
[12]	Pavic M, Bogowicz M, Würms X, et al. Influence of inter-observer delineation variability on radiomics stability in different tumor sites[J]. Acta Oncol, 2018, 57(8):1070-1074. DOI: 10.1080/0284186X.2018.1445283. doi: 10.1080/0284186X.2018.1445283
[13]	刘陈路, 马长升, 陈进琥, 等. PET-CT SUV阈值对非小细胞肺癌靶区勾画体积及对影像组学指标的影响[J]. 中华肿瘤防治杂志, 2020, 27(22):1815-1820. DOI: 10.16073/j.cnki.cjcpt.2020.22.07. doi: 10.16073/j.cnki.cjcpt.2020.22.07
[14]	Yousaf T, Dervenoulas G, Politis M. Advances in MRI methodology[J]. Int Rev Neurobiol, 2018, 141:31-76. DOI: 10.1016/bs.irn.2018.08.008. doi: 10.1016/bs.irn.2018.08.008
[15]	Khalil A, Majlath M, Gounant V, et al. Contribution of magnetic resonance imaging in lung cancer imaging[J]. Diagn Interv Imaging, 2016, 97(10):991-1002. DOI: 10.1016/j.diii.2016.08.015. doi: 10.1016/j.diii.2016.08.015
[16]	Zhang X, Fu Z, Gong G, et al. Implementation of diffusion-weighted magnetic resonance imaging in target delineation of central lung cancer accompanied with atelectasis in precision radiotherapy[J]. Oncol Lett, 2017, 14(3):2677-2682. DOI: 10.3892/ol.2017.6479. doi: 10.3892/ol.2017.6479
[17]	谢青, 任彤, 孙梅, 等. DWI-MRI对区分中央型肺癌与阻塞性肺不张的价值[J]. 中国临床研究, 2020, 33(8):1097-1100. DOI: 10.13429/j.cnki.cjcr.2020.08.023. doi: 10.13429/j.cnki.cjcr.2020.08.023
[18]	Eun NL, Kang D, Son EJ, et al. Texture analysis with 3.0-T MRI for association of response to neoadjuvant chemotherapy in breast cancer[J]. Radiology, 2020, 294(1):31-41. DOI: 10.1148/radiol.2019182718. doi: 10.1148/radiol.2019182718
[19]	Sarioglu FC, Sarioglu O, Guleryuz H, et al. MRI-based texture analysis for differentiating pediatric craniofacial rhabdomyosarcoma from infantile hemangioma[J]. Eur Radiol, 2020, 30(10):5227-5236. DOI: 10.1007/s00330-020-06908-4. doi: 10.1007/s00330-020-06908-4 pmid: 32382846
[20]	Sarioglu O, Sarioglu FC, Akdogan AI, et al. MRI-based texture analysis to differentiate the most common parotid tumours[J]. Clin Radiol, 2020, 75(11): 877.e15-877.e23. DOI: 10.1016/j.crad.2020.06.018. doi: 10.1016/j.crad.2020.06.018
[21]	Mao J, Fang J, Duan X, et al. Predictive value of pretreatment MRI texture analysis in patients with primary nasopharyngeal carcinoma[J]. Eur Radiol, 2019, 29(8):4105-4113. DOI: 10.1007/s00330-018-5961-6. doi: 10.1007/s00330-018-5961-6
[22]	Ortiz-Ramón R, Ruiz-Espana S, Mollá-Olmos E, et al. Glioblastomas and brain metastases differentiation following an MRI texture analysis-based radiomics approach[J]. Phys Med, 2020, 76:44-54. DOI: 10.1016/j.ejmp.2020.06.016. doi: S1120-1797(20)30149-6 pmid: 32593138
[23]	Xu J, Cui X, Wang B, et al. Texture analysis of early cerebral tissue damage in magnetic resonance imaging of patients with lung cancer[J]. Oncol Lett, 2020, 19(4):3089-3100. DOI: 10.3892/ol.2020.11426. doi: 10.3892/ol.2020.11426
[24]	Mahon RN, Hugo GD, Weiss E. Repeatability of texture features derived from magnetic resonance and computed tomography imaging and use in predictive models for non-small cell lung cancer outcome[J]. Phys Med Biol, 2019, 64(14):145007. DOI: 10.1088/1361-6560/ab18d3. doi: 10.1088/1361-6560/ab18d3
[25]	Wang C, Tyagi N, Rimner A, et al. Segmenting lung tumors on longitudinal imaging studies via a patient-specific adaptive convolutional neural network[J]. Radiother Oncol, 2019, 131:101-107. DOI: 10.1016/j.radonc.2018.10.037. doi: 10.1016/j.radonc.2018.10.037
[26]	Hearn N, Bugg W, Chan A, et al. Manual and semi-automated delineation of locally advanced rectal cancer subvolumes with diffusion-weighted MRI[J]. Br J Radiol, 2020, 93(1114):20200543. DOI: 10.1259/bjr.20200543. doi: 10.1259/bjr.20200543
[27]	邹茂扬, 杨昊, 潘光晖, 等. 深度学习在医学图像配准上的研究进展与挑战[J]. 生物医学工程学杂志, 2019, 36(4):677-683. DOI: 10.7507/1001-5515.201810004. doi: 10.7507/1001-5515.201810004
[28]	Hu R, Wang H, Ristaniemi T, et al. Lung CT image registration through landmark-constrained learning with convolutional neural network[J]. Annu Int Conf IEEE Eng Med Biol Soc, 2020, 2020:1368-1371. DOI: 10.1109/EMBC44109.2020.9176363. doi: 10.1109/EMBC44109.2020.9176363
[29]	Han Q, Liang H, Cheng P, et al. Comparison of different registration landmarks for MRI-CT fusion in radiotherapy for lung cancer with post-obstructive lobar collapse[J]. J Appl Clin Med Phys, 2019, 20(1):50-54. DOI: 10.1002/acm2.12495. doi: 10.1002/acm2.12495
[30]	Higgins J, Bezjak A, Franks K, et al. Comparison of spine, carina, and tumor as registration landmarks for volumetric image-guided lung radiotherapy[J]. Int J Radiat Oncol Biol Phys, 2009, 73(5):1404-1413. DOI: 10.1016/j.ijrobp.2008.06.1926. doi: 10.1016/j.ijrobp.2008.06.1926
[31]	de Vos BD, Berendsen FF, Viergever MA, et al. A deep learning framework for unsupervised affine and deformable image registration[J]. Med Image Anal, 2019, 52:128-143. DOI: 10.1016/j.media.2018.11.010. doi: 10.1016/j.media.2018.11.010
[32]	Aldosary G, Szanto J, Holmes O, et al. Geometric inaccuracy and co-registration errors for CT, DynaCT and MRI images used in robotic stereotactic radiosurgery treatment planning[J]. Phys Med, 2020, 69:212-222. DOI: 10.1016/j.ejmp.2019.12.002. doi: S1120-1797(19)30523-X pmid: 31918373
[33]	刘士远, 肖湘生, 李成州, 等. MRI区分肺癌肿块与阻塞性肺炎或肺不张: 与CT对照[J]. 中国医学计算机成像杂志, 1997, (3):172-174. DOI: 10.19627/j.cnki.cn31-1700/th.1997.03.008. doi: 10.19627/j.cnki.cn31-1700/th.1997.03.008
[34]	Li L, Lu W, Tan S. Variational PET/CT tumor co-segmentation integrated with PET restoration[J]. IEEE Trans Radiat Plasma Med Sci, 2020, 4(1):37-49. DOI: 10.1109/trpms.2019.2911597. doi: 10.1109/trpms.2019.2911597
[35]	Sindoni A, Minutoli F, Pontoriero A, et al. Usefulness of four dimensional (4D) PET/CT imaging in the evaluation of thoracic lesions and in radiotherapy planning: review of the literature[J]. Lung Cancer, 2016, 96:78-86. DOI: 10.1016/j.lungcan.2016.03.019. doi: 10.1016/j.lungcan.2016.03.019
[36]	Reinartz G, Haverkamp U, Wullenkord R, et al. 4D-Listmode-PET-CT and 4D-CT for optimizing PTV margins in gastric lymphoma: determination of intra- and interfractional gastric motion[J]. Strahlenther Onkol, 2016, 192(5):322-332. DOI: 10.1007/s00066-016-0949-0. doi: 10.1007/s00066-016-0949-0
[37]	Scarsbrook A, Ward G, Murray P, et al. Respiratory-gated (4D) contrast-enhanced FDG PET-CT for radiotherapy planning of lower oesophageal carcinoma: feasibility and impact on planning target volume[J]. BMC Cancer, 2017, 17(1):671. DOI: 10.1186/s12885-017-3659-9. doi: 10.1186/s12885-017-3659-9 pmid: 28978306
[38]	Hapdey S, Dubray B, Chastan M, et al. Respiratory gated multistatic PET reconstructions to delineate radiotherapy target volume in patients with mobile lung tumours[J]. Q J Nucl Med Mol Imaging, 2020. DOI: 10.23736/S1824-4785.19.03183-2. doi: 10.23736/S1824-4785.19.03183-2
[39]	Navest RJM, Mandija S, Bruijnen T, et al. The noise navigator: a surrogate for respiratory-correlated 4D-MRI for motion characterization in radiotherapy[J]. Phys Med Biol, 2020, 65(1): 01NT02. DOI: 10.1088/1361-6560/ab5c62. doi: 10.1088/1361-6560/ab5c62
[40]	Wang FL, Tan YY, Gu XM, et al. Comparison of positron emission tomography using 2-[¹⁸F]-fluoro-2-deoxy-D-glucose and 3-deoxy-3-[¹⁸F]-fluorothymidine in lung cancer imaging[J]. Chin Med J (Engl), 2016, 129(24):2926-2935. DOI: 10.4103/0366-6999.195468. doi: 10.4103/0366-6999.195468
[41]	Shimizu K, Kaira K, Higuchi T, et al. Relationship between tumor immune markers and fluorine-18-α-methyltyrosine ([¹⁸F]FAMT) uptake in patients with lung cancer[J]. Mol Imaging Biol, 2020, 22(4):1078-1086. DOI: 10.1007/s11307-019-01456-w. doi: 10.1007/s11307-019-01456-w
[42]	Cheng G. Non-small-cell lung cancer PET imaging beyond F18 fluorodeoxyglucose[J]. PET Clin, 2018, 13(1):73-81. DOI: 10.1016/j.cpet.2017.09.006. doi: S1556-8598(17)30103-7 pmid: 29157387
[43]	Windisch P, Zwahlen DR, Koerber SA, et al. Clinical results of fibroblast activation protein (FAP) specific PET and implications for radiotherapy planning: systematic review[J]. Cancers (Basel), 2020, 12(9):2629. DOI: 10.3390/cancers12092629. doi: 10.3390/cancers12092629
[44]	Prosch H. Pulmonary carcinoid tumors[J]. Radiologe, 2017, 57(5):397-406. DOI: 10.1007/s00117-017-0243-x. doi: 10.1007/s00117-017-0243-x pmid: 28405692